Kewaunee scientific corp /de/ (KEQU)
CashFlow / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10Jul'10
Cash flows from operating activities:
Net earnings (loss)

-1,901

-2,161

496

-1,197

15

1,372

1,498

1,553

948

1,765

1,192

1,395

358

1,537

1,330

1,359

848

707

963

1,260

1,015

625

746

1,617

1,404

782

807

688

1,814

34

-156

108

369

125

880

724

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation

635

648

644

663

645

634

629

657

701

717

686

742

659

654

647

742

623

606

621

628

703

598

617

631

659

677

659

658

670

651

666

677

671

627

600

589

Bad debt provision

249

36

36

8

37

64

-44

273

26

39

6

79

-65

8

15

-

-

-

-

26

7

38

42

29

42

-31

-2

25

169

29

10

6

41

-66

42

43

Stock based compensation expense

126

41

74

-196

118

139

136

79

98

126

52

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for deferred income taxes

-671

1,743

-16

-

212

154

-11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

52

51

47

-

50

49

47

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for deferred income tax expense

-

-

-

-

-

-

-

-

-

-

45

-

-

-

-39

-375

60

-10

-10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58

-

-

66

59

59

59

57

64

-

-

-

-

-

-

-

-

Provision for deferred income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15

-

-38

-7

-35

-421

-9

-59

-37

-1,372

-43

-62

-62

352

35

-135

-29

Change in assets and liabilities:
Receivables

-4,359

-4,179

3,008

5,338

-1,819

-6,199

3,344

2,090

-2,376

9,649

-6,248

4,181

-3,318

-1,469

2,697

-1,507

820

479

-989

2,262

1,510

1,558

-4,260

-1,103

5,862

-4,525

2,610

-1,273

2,592

-3,404

-3,793

-58

6,331

-6,003

-390

1,299

Inventories

469

-1,573

-855

534

-425

1,982

-2,547

76

1,286

-562

2,066

-796

-1,058

4

1,159

-528

2,414

-230

1,225

275

-569

-667

840

-869

315

464

707

-43

-2

1,392

109

-205

-55

1,463

832

-124

Accounts payable and other accrued expenses

-2,289

-1,058

835

4,824

-677

-2,027

-2,175

2,571

-1,479

3,930

-416

1,875

-1,645

-1,539

1,995

-312

2,480

-1,266

449

877

-735

71

-93

-2,105

2,447

-3,191

2,580

768

2,102

-86

-1,160

-1,315

-506

-148

423

-441

Deferred revenue

-232

509

-76

-

-113

-194

-127

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

733

-5,033

5,258

-567

304

26

102

-10

91

386

146

-34

103

-580

160

-451

184

-151

-456

-263

-211

-390

343

105

104

185

128

Other, net

308

-607

-247

-270

-248

771

-1,938

448

-958

-871

-184

-448

445

-89

-345

471

475

388

-699

-638

-174

469

180

-523

937

542

-1,050

-296

1,432

285

324

-907

155

439

-986

73

Net cash (used in) provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

3,645

2,386

-180

-

1,275

340

1,521

-195

-

-

-

1,805

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

115

4,903

-407

-2,044

2,233

5,130

-2,829

3,828

1,468

-2,643

530

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,074

-476

2,730

-

2,383

2,813

-887

-4,864

5,656

567

-88

Cash flows from investing activities:
Capital expenditures

656

-468

1,183

1,923

979

701

610

1,488

470

1,002

435

421

428

706

1,056

479

447

789

472

541

407

426

660

528

867

809

295

434

205

479

447

304

549

986

1,533

2,179

Decrease (increase) in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-3

-211

23

59

123

-235

-285

-312

1,968

-309

74

-16

-72

-1

53

-14

-51

55

-227

-32

355

-

-

-

-23

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-217

-729

-1,115

-

-212

-504

-160

-2,509

-

-

-

-456

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-656

468

-1,183

-1,923

-979

-701

-610

-1,488

-470

-1,002

-435

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-862

-281

-383

-

-252

-415

-659

-558

-986

-1,556

-2,156

Cash flows from financing activities:
Dividends paid

0

523

522

523

521

521

465

463

463

462

406

407

406

407

350

349

348

348

316

288

288

287

287

260

251

267

259

258

258

257

258

258

258

258

257

257

Dividends paid to noncontrolling interest in subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term borrowings

13,502

14,806

16,650

16,543

11,968

14,346

19,789

14,430

16,163

13,779

14,697

11,603

10,202

13,762

15,840

-

-

-

-

-

-

-

-

-

-

-

-

-315

-

-

-

2,084

5,892

-3,451

-3,349

2,624

Repayments on short-term borrowings

16,245

21,325

12,884

12,148

11,508

17,216

16,146

15,323

19,096

9,607

14,749

12,691

12,245

13,998

12,700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on long-term debt and lease obligations

4

977

296

-

297

291

292

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in short-term borrowings and interest rate swaps

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

628

-54

2,064

-1,019

-7,106

6,174

-1,896

-

-

-

-

-

-

-

-

-

-

-

-

Payments on long-term debt and lease obligations

-

-

-

-

-

-

-

-

-

-

105

105

106

105

105

106

105

105

106

105

106

105

139

3,504

50

50

50

50

50

50

50

50

-

-

-

-

Net proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

0

38

103

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

15

21

22

21

20

20

20

20

18

24

Payment toward purchase of noncontrolling interest in subsidiary

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

888

888

0

0

0

1,780

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from exercise of stock options

0

0

-14

-7

0

1

-30

0

0

-1

9

-

-

-

-

-

-

-

-

-

33

0

2

57

22

27

35

32

-

-

-

-

65

-32

0

1

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-2,555

-710

2,788

-

-443

633

-1,439

783

-

-

-

-2,383

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-2,982

-8,108

2,934

3,568

-409

-3,681

2,856

-1,648

-3,688

3,406

-554

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,882

-1,235

-612

-

-1,253

-1,674

1,756

5,567

-3,747

343

2,342

Effect of exchange rate changes on cash and cash equivalents

-12

-246

81

178

376

-679

-288

-405

177

-69

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash, cash equivalents and restricted cash

-3,535

-2,983

1,425

-221

1,221

69

-871

287

-2,513

-308

-449

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

466

-198

-79

-4

135

-185

-94

-67

41

231

-220

-27

-369

-35

-6

150

-203

-180

-161

-164

40

97

-11

82

-8

(Decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

4,252

675

868

1,489

1,513

435

375

-145

-1,880

-410

1,374

876

-1,403

1,609

-1,676

-1,842

1,532

2,259

717

560

250

242

912

-564

90

Purchase of noncontrolling interest in subsidiary - Other accrued expenses and other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,775

-

-

-

-

-

-

-

-

-

-

-

-